Yahoo Web Search

Search results

1. Top Stories

   • 
     Forbes

     Novavax Shares Surge Over 130% After $1.4 Billion Covid Shot Deal With Sanofi

     The biotech company said it would develop a combination Covid and flu shot with Sanofi as part of a billion-dollar deal.

     1 day ago

   • 

     Reuters on MSN.com

     Novavax signs COVID-19 license deal with Sanofi, revokes 'going concern' warning

     1 day ago

   • 

     Reuters on MSN.com

     Novavax shares soar on license deal with Sanofi at lofty valuation

     24 hours ago

   • 

     MM&M

     Sanofi strikes licensing pact with Novavax for COVID, flu-COVID combo shots

     2 days ago

   • FierceBiotech

     Sanofi CSO Frank Nestle is leaving

     3 days ago

   View all

2. www.pharmaceutical-technology.com › news › sanofiSanofi signs $1.2bn licensing agreement for Novavax’s Covid ...

   www.pharmaceutical-technology.com › news › sanofi

   • Cached

   1 day ago · Sanofi has signed a $1.2bn licensing agreement with Novavax to co-commercialise its stand-alone adjuvanted Covid-19 vaccine.. Starting in 2025, the drugmaker will co-commercialise the vaccine worldwide, except for in countries such as India, South Korea, and Japan where Novavax already has existing partnerships in place.

3. www.cnbc.com › 2024/05/10 › novavax-and-sanofi-toNovavax and Sanofi to commercialize Covid vaccine, develop ...

   www.cnbc.com › 2024/05/10 › novavax-and-sanofi-to

   • Cached

   1 day ago · Novavax has signed a multibillion-dollar deal with French drugmaker Sanofi to co-commercialize the company’s Covid vaccine starting next year. Part of the deal allows Sanofi to use Novavax’s ...

4. www.fiercepharma.com › pharma › sanofi-keeps-novavaxSanofi pays $1.2B to partner with Novavax on COVID-19 vaccine

   www.fiercepharma.com › pharma › sanofi-keeps-novavax

   • Cached

   1 day ago · By Kevin Dunleavy May 10, 2024 10:53am. Novavax Sanofi COVID-19 Quarterly Sales. On a day when struggling Novavax slashed its 2024 revenue projection from a range of $800 million to $1 million to ...

5. www.forbes.com › sites › tylerroushNovavax Shares Surge 130% After $1.4 Billion Sanofi Deal - Forbes

   www.forbes.com › sites › tylerroush

   • Cached

   1 day ago · Topline. Shares for Novavax swelled by more than 130% Friday morning, after the biotech firm announced a $1.4 billion deal with Sanofi to commercialize its Covid vaccine and develop a new ...

6. www.reuters.com › business › healthcareNovavax shares soar on license deal with Sanofi at lofty ...

   www.reuters.com › business › healthcare

   1 day ago · At their peak in 2021, its shares traded at about $332. Sanofi will take a 4.9% stake in the U.S. drugmaker for $70 million. That values Novavax at about $1.4 billion, nearly double its market ...

7. www.statnews.com › 2024/05/10 › sanofi-vaccinesSanofi strikes deal with Novavax, boosting the vaccine maker

   www.statnews.com › 2024/05/10 › sanofi-vaccines

   • Cached

   1 day ago · Sanofi on Friday said it had reached a deal worth up to $1.2 billion to sell Novavax’s Covid shot as well as to try to combine the vaccine with its own flu shot.

8. www.axios.com › 2024/05/10 › novavax-sanofi-fluNovavax strikes $1.2 billion deal with Sanofi - Axios

   www.axios.com › 2024/05/10 › novavax-sanofi-flu

   • Cached

   1 day ago · The French drug giant Sanofi is taking a minority stake in Novavax and entering into a licensing agreement worth as much as $1.2 billion that includes selling a combination COVID-flu shot. Why it matters: It's a major turnaround for Maryland-based Novavax, one of America's first big bets under Operation Warp Speed that lost out in the COVID-19 ...